Dr James Davis Russell, MD | |
1521 N 10th St, Ste C, Blytheville, AR 72315-1405 | |
(870) 762-5360 | |
(870) 762-1146 |
Full Name | Dr James Davis Russell |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 1521 N 10th St, Blytheville, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497724223 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | C4640 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr James Davis Russell, MD 1521 N 10th St, Ste C, Blytheville, AR 72315-1405 Ph: (870) 762-5360 | Dr James Davis Russell, MD 1521 N 10th St, Ste C, Blytheville, AR 72315-1405 Ph: (870) 762-5360 |
News Archive
Covidien, a leading global provider of healthcare products and the world's largest producer of acetaminophen, supports the U.S. Food and Drug Administration (FDA) on the safe use of acetaminophen.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
Kaiser Health News staff writer Marilyn Werber Serafini, working in collaboration with The Washington Post, writes: When Dillon Pefok agreed to coach a men's soccer team in the District's Soccer 4 Jesus church league, it wasn't his intention to teach the players about the 2010 health-care law between drills.
Training programs designed to help information technology (IT) companies broaden their business skills and knowledge in the emerging areas of healthcare IT and unified communications are available in the coming weeks from CompTIA, the non-profit association for the IT industry.
Today at the XVIII International AIDS Conference in Vienna, Austria, members of the International Rectal Microbicide Advocates (IRMA) and thousands of other HIV advocates and scientists cheered a long-awaited, much anticipated success in the quest for new HIV prevention technologies. Researchers announced that a vaginal gel has been shown to significantly reduce a woman's risk of being infected with HIV and genital herpes
› Verified 9 days ago